1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Therapy Market Perspective (2018-2029)
2.2 Radiopharmaceutical Therapy Growth Trends by Region
2.2.1 Global Radiopharmaceutical Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiopharmaceutical Therapy Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceutical Therapy Forecasted Market Size by Region (2024-2029)
2.3 Radiopharmaceutical Therapy Market Dynamics
2.3.1 Radiopharmaceutical Therapy Industry Trends
2.3.2 Radiopharmaceutical Therapy Market Drivers
2.3.3 Radiopharmaceutical Therapy Market Challenges
2.3.4 Radiopharmaceutical Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Therapy Players by Revenue
3.1.1 Global Top Radiopharmaceutical Therapy Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceutical Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Therapy Revenue
3.4 Global Radiopharmaceutical Therapy Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Therapy Revenue in 2022
3.5 Radiopharmaceutical Therapy Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Therapy Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Therapy Breakdown Data by Type
4.1 Global Radiopharmaceutical Therapy Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Type (2024-2029)
5 Radiopharmaceutical Therapy Breakdown Data by Application
5.1 Global Radiopharmaceutical Therapy Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radiopharmaceutical Therapy Market Size (2018-2029)
6.2 North America Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiopharmaceutical Therapy Market Size by Country (2018-2023)
6.4 North America Radiopharmaceutical Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiopharmaceutical Therapy Market Size (2018-2029)
7.2 Europe Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiopharmaceutical Therapy Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceutical Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Therapy Market Size (2018-2029)
8.2 Asia-Pacific Radiopharmaceutical Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Therapy Market Size (2018-2029)
9.2 Latin America Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiopharmaceutical Therapy Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceutical Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Therapy Market Size (2018-2029)
10.2 Middle East & Africa Radiopharmaceutical Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Detail
11.1.2 Bracco Imaging Business Overview
11.1.3 Bracco Imaging Radiopharmaceutical Therapy Introduction
11.1.4 Bracco Imaging Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Radiopharmaceutical Therapy Introduction
11.2.4 Bayer Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Detail
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Radiopharmaceutical Therapy Introduction
11.3.4 Mallinckrodt Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.3.5 Mallinckrodt Recent Development
11.4 Nordion
11.4.1 Nordion Company Detail
11.4.2 Nordion Business Overview
11.4.3 Nordion Radiopharmaceutical Therapy Introduction
11.4.4 Nordion Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Detail
11.5.2 Triad Isotopes Business Overview
11.5.3 Triad Isotopes Radiopharmaceutical Therapy Introduction
11.5.4 Triad Isotopes Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Detail
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Radiopharmaceutical Therapy Introduction
11.6.4 Lantheus Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.6.5 Lantheus Recent Development
11.7 IBA Group
11.7.1 IBA Group Company Detail
11.7.2 IBA Group Business Overview
11.7.3 IBA Group Radiopharmaceutical Therapy Introduction
11.7.4 IBA Group Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.7.5 IBA Group Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Radiopharmaceutical Therapy Introduction
11.8.4 GE Healthcare Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.8.5 GE Healthcare Recent Development
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Detail
11.9.2 China Isotope & Radiation Business Overview
11.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Introduction
11.9.4 China Isotope & Radiation Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.9.5 China Isotope & Radiation Recent Development
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Detail
11.10.2 Jubilant Pharma Business Overview
11.10.3 Jubilant Pharma Radiopharmaceutical Therapy Introduction
11.10.4 Jubilant Pharma Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.10.5 Jubilant Pharma Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Radiopharmaceutical Therapy Introduction
11.11.4 Eli Lilly Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.11.5 Eli Lilly Recent Development
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Company Detail
11.12.2 Advanced Accelerator Applications Business Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Introduction
11.12.4 Advanced Accelerator Applications Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.12.5 Advanced Accelerator Applications Recent Development
11.13 SIEMENS
11.13.1 SIEMENS Company Detail
11.13.2 SIEMENS Business Overview
11.13.3 SIEMENS Radiopharmaceutical Therapy Introduction
11.13.4 SIEMENS Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.13.5 SIEMENS Recent Development
11.14 Dongcheng
11.14.1 Dongcheng Company Detail
11.14.2 Dongcheng Business Overview
11.14.3 Dongcheng Radiopharmaceutical Therapy Introduction
11.14.4 Dongcheng Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.14.5 Dongcheng Recent Development
11.15 Navidea
11.15.1 Navidea Company Detail
11.15.2 Navidea Business Overview
11.15.3 Navidea Radiopharmaceutical Therapy Introduction
11.15.4 Navidea Revenue in Radiopharmaceutical Therapy Business (2018-2023)
11.15.5 Navidea Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer